These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 20843690)

  • 1. Piperidine-based renin inhibitors: upper chain optimization.
    Corminboeuf O; Bezençon O; Remeň L; Grisostomi C; Richard-Bildstein S; Bur D; Prade L; Strickner P; Hess P; Fischli W; Steiner B; Treiber A
    Bioorg Med Chem Lett; 2010 Nov; 20(21):6291-6. PubMed ID: 20843690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and optimization of new piperidines as renin inhibitors.
    Corminboeuf O; Bezençon O; Grisostomi C; Remeň L; Richard-Bildstein S; Bur D; Prade L; Hess P; Strickner P; Fischli W; Steiner B; Treiber A
    Bioorg Med Chem Lett; 2010 Nov; 20(21):6286-90. PubMed ID: 20843686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renin inhibitors for the treatment of hypertension: design and optimization of a novel series of pyridone-substituted piperidines.
    Chen A; Campeau LC; Cauchon E; Chefson A; Ducharme Y; Dubé D; Falgueyret JP; Fournier PA; Gagné S; Grimm E; Han Y; Houle R; Huang JQ; Lacombe P; Laliberté S; Lévesque JF; Liu S; MacDonald D; Mackay B; McKay D; Percival MD; Regan C; Regan H; St-Jacques R; Toulmond S
    Bioorg Med Chem Lett; 2011 Jul; 21(13):3970-5. PubMed ID: 21621998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The discovery and preparation of disubstituted novel amino-aryl-piperidine-based renin inhibitors.
    Cody WL; Holsworth DD; Powell NA; Jalaie M; Zhang E; Wang W; Samas B; Bryant J; Ostroski R; Ryan MJ; Edmunds JJ
    Bioorg Med Chem; 2005 Jan; 13(1):59-68. PubMed ID: 15582452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of CYP450 inhibition in the 4-[(1H-imidazol-4-yl)methyl]piperidine series of histamine H3 receptor antagonists.
    Berlin M; Ting PC; Vaccaro WD; Aslanian R; McCormick KD; Lee JF; Albanese MM; Mutahi MW; Piwinski JJ; Shih NY; Duguma L; Solomon DM; Zhou W; Sher R; Favreau L; Bryant M; Korfmacher WA; Nardo C; West RE; Anthes JC; Williams SM; Wu RL; Susan She H; Rivelli MA; Corboz MR; Hey JA
    Bioorg Med Chem Lett; 2006 Feb; 16(4):989-94. PubMed ID: 16297617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A practical synthesis of renin inhibitor MK-1597 (ACT-178882) via catalytic enantioselective hydrogenation and epimerization of piperidine intermediate.
    Molinaro C; Shultz S; Roy A; Lau S; Trinh T; Angelaud R; O'Shea PD; Abele S; Cameron M; Corley E; Funel JA; Steinhuebel D; Weisel M; Krska S
    J Org Chem; 2011 Feb; 76(4):1062-71. PubMed ID: 21250716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of piperidine farnesyltransferase inhibitors with reduced glucuronidation potential.
    Tanaka R; Rubio A; Harn NK; Gernert D; Grese TA; Eishima J; Hara M; Yoda N; Ohashi R; Kuwabara T; Soga S; Akinaga S; Nara S; Kanda Y
    Bioorg Med Chem; 2007 Feb; 15(3):1363-82. PubMed ID: 17127066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and discovery of new (3S,5R)-5-[4-(2-chlorophenyl)-2,2-dimethyl-5-oxopiperazin-1-yl]piperidine-3-carboxamides as potent renin inhibitors.
    Mori Y; Ogawa Y; Mochizuki A; Nakamura Y; Sugita C; Miyazaki S; Tamaki K; Matsui Y; Takahashi M; Nagayama T; Nagai Y; Inoue S; Nishi T
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7677-82. PubMed ID: 23122821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of orally bioavailable alkyl amine renin inhibitors.
    Xu Z; Cacatian S; Yuan J; Simpson RD; Jia L; Zhao W; Tice CM; Flaherty PT; Guo J; Ishchenko A; Singh SB; Wu Z; McKeever BM; Scott BB; Bukhtiyarov Y; Berbaum J; Mason J; Panemangalore R; Cappiello MG; Bentley R; Doe CP; Harrison RK; McGeehan GM; Dillard LW; Baldwin JJ; Claremon DA
    Bioorg Med Chem Lett; 2010 Jan; 20(2):694-9. PubMed ID: 19959358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and campaign synthesis of piperidine- and thiazole-based histone deacetylase inhibitors.
    Andrews DM; Stokes ES; Carr GR; Matusiak ZS; Roberts CA; Waring MJ; Brady MC; Chresta CM; East SJ
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2580-4. PubMed ID: 18378449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and structure-activity relationships of novel piperidine inhibitors of farnesyltransferase.
    Nara S; Tanaka R; Eishima J; Hara M; Takahashi Y; Otaki S; Foglesong RJ; Hughes PF; Turkington S; Kanda Y
    J Med Chem; 2003 Jun; 46(12):2467-73. PubMed ID: 12773050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based optimization of potent 4- and 6-azaindole-3-carboxamides as renin inhibitors.
    Scheiper B; Matter H; Steinhagen H; Böcskei Z; Fleury V; McCort G
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5480-6. PubMed ID: 21840218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and preparation of potent, nonpeptidic, bioavailable renin inhibitors.
    Bezençon O; Bur D; Weller T; Richard-Bildstein S; Remen L; Sifferlen T; Corminboeuf O; Grisostomi C; Boss C; Prade L; Delahaye S; Treiber A; Strickner P; Binkert C; Hess P; Steiner B; Fischli W
    J Med Chem; 2009 Jun; 52(12):3689-702. PubMed ID: 19358611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of disubstituted (4-piperidinyl)-piperazine derivatives as potent acetyl-CoA carboxylase inhibitors.
    Chonan T; Tanaka H; Yamamoto D; Yashiro M; Oi T; Wakasugi D; Ohoka-Sugita A; Io F; Koretsune H; Hiratate A
    Bioorg Med Chem Lett; 2010 Jul; 20(13):3965-8. PubMed ID: 20537533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of novel SCD1 inhibitors: 5-alkyl-4,5-dihydro-3H-spiro[1,5-benzoxazepine-2,4'-piperidine] analogs.
    Uto Y; Ueno Y; Kiyotsuka Y; Miyazawa Y; Kurata H; Ogata T; Takagi T; Wakimoto S; Ohsumi J
    Eur J Med Chem; 2011 May; 46(5):1892-6. PubMed ID: 21356569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (4-Piperidinyl)-piperazine: a new platform for acetyl-CoA carboxylase inhibitors.
    Chonan T; Oi T; Yamamoto D; Yashiro M; Wakasugi D; Tanaka H; Ohoka-Sugita A; Io F; Koretsune H; Hiratate A
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6645-8. PubMed ID: 19853443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based design and optimization of potent renin inhibitors on 5- or 7-azaindole-scaffolds.
    Matter H; Scheiper B; Steinhagen H; Böcskei Z; Fleury V; McCort G
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5487-92. PubMed ID: 21840215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and optimization of novel (3S,5R)-5-(2,2-dimethyl-5-oxo-4-phenylpiperazin-1-yl)piperidine-3-carboxamides as orally active renin inhibitors.
    Mori Y; Ogawa Y; Mochizuki A; Nakamura Y; Fujimoto T; Sugita C; Miyazaki S; Tamaki K; Nagayama T; Nagai Y; Inoue S; Chiba K; Nishi T
    Bioorg Med Chem; 2013 Sep; 21(18):5907-22. PubMed ID: 23886807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of piperidine-aryl urea-based stearoyl-CoA desaturase 1 inhibitors.
    Xin Z; Zhao H; Serby MD; Liu B; Liu M; Szczepankiewicz BG; Nelson LT; Smith HT; Suhar TS; Janis RS; Cao N; Camp HS; Collins CA; Sham HL; Surowy TK; Liu G
    Bioorg Med Chem Lett; 2008 Aug; 18(15):4298-302. PubMed ID: 18632269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of passive permeability and gut efflux transport on the oral bioavailability of novel series of piperidine-based renin inhibitors in rodents.
    Lévesque JF; Bleasby K; Chefson A; Chen A; Dubé D; Ducharme Y; Fournier PA; Gagné S; Gallant M; Grimm E; Hafey M; Han Y; Houle R; Lacombe P; Laliberté S; MacDonald D; Mackay B; Papp R; Tschirret-Guth R
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5547-51. PubMed ID: 21784634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.